e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The need for a better identification of COPD-bronchiectasis phenotype
A. de Sousa Fernandes (Oliveira de Azeméis, Portugal)
Source:
International Congress 2017 – Management of COPD
Session:
Management of COPD
Session type:
Poster Discussion
Number:
3249
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. de Sousa Fernandes (Oliveira de Azeméis, Portugal). The need for a better identification of COPD-bronchiectasis phenotype. 3249
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
A new score to identify patients who need fitness to fly test
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018
What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline?
Source: ERS Research Seminar 2016
Year: 2016
COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging
Source: Eur Respir J, 52 (5) 1801570; 10.1183/13993003.01570-2018
Year: 2018
Population segmentation to identify priority targets for identification and behaviour change interventions in COPD
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011
A simple algorithm for the identification of clinical COPD phenotypes
Source: Eur Respir J, 50 (5) 1701034; 10.1183/13993003.01034-2017
Year: 2017
Characterisation of clinical phenotypes is mandatory for the development of new drugs
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
The role of gene–environment interactions in lung disease: the urgent need for the exposome
Source: Eur Respir J, 55 (2) 1902064; 10.1183/13993003.02064-2019
Year: 2020
What regulatory framework is preferable for successful harm reduction?
Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies
Year: 2005
Genetic studies as a tool for identifying novel potential targets for treatment of COPD
Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017
Year: 2017
The impact of a new recruitment strategy to improve recruitment of participants to research studies
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
Can lung function tests help identify functional phenotypes in children with asthma?
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021
Physicians or prediction rules; who is better at predicting prognosis?
Source: Eur Respir J 2007; 30: Suppl. 51, 124s
Year: 2007
How can we achieve better prevention of progression to tuberculosis among contacts?
Source: Eur Respir J 2013; 42: 1743-1746
Year: 2013
The need and potential of patient-specific modelling
Source: Annual Congress 2012 - PG13 AirPROM: patient-specific modelling and systems biology living labs workshop
Year: 2012
TB education - a method for better therapeutic results
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002
Using population insight studies to define effective prevention and identification interventions in COPD
Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care
Year: 2011
The goal is to go further and do better: but how?
Source: Eur Respir Rev 2015; 25: 1-3
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept